GL
GlenmarkPh n4.5%210802S
4N4B
General Announcement::GPL Announces Initiation of a Phase 2b Trial of GBR 830 for the Treatment of Atopic Dermatitis
Original SGX announcement
Read the archived filing
Membership includes the on-site filing reader and available attachments.
SGD 5 / month
Billed automatically. Cancel any time.
Sign in to subscribeWhat membership includes
- Full recorded dividend history
- Archived SGX filing details and available attachments
- Ad-free browsing